Mounjaro users in UK warned against bulk buying before autumn price rise
Briefly

Eli Lilly plans to increase Mounjaro prices in the UK by as much as 170% from September. The company said the NHS will be shielded from the rise, but most users buy privately because few people qualify for NHS access. One month's supply of the highest dose currently costs about £200 through many online pharmacies and is expected to increase. The National Pharmacy Association warned against bulk ordering and buying from unlicensed sellers because bulk buying can strain supply and unlicensed products may be fake or unsafe. Patients are urged to speak to their prescribers for support and safe care.
The US pharmaceutical company Eli Lilly, which makes Mounjaro, recently announced plans to increase the price of the medication in the UK by as much as 170% from September. The move follows pressure from the US president, Donald Trump, to cut medication prices for Americans. Eli Lilly has said the NHS will be shielded from the price rise, but with few people eligible for access through the health service, most purchase Mounjaro privately.
We'd urge patients to avoid bulk ordering Mounjaro as well as buying the medication at massively reduced prices, he said. Bulk ordering can have a significant impact on supply and pose a potential risk to patient safety. We'd also urge patients to avoid unlicensed sellers, who may be selling fake medication or medication that does not meet UK safety standards. Instead, we'd encourage them to speak to their prescriber, who can support them with any concerns they may have and provide them with the safe care they need.
Read at www.theguardian.com
[
|
]